Daphne Board of Directors Office       The 8th Issue            April 29, 2011

      Good news came from Shanghai on April 23, 2011: Daphne panax notoginseng capsules won a tender of the Shanghai central drug purchase system. 

      Daphne panax notoginseng capsules, 300mg¡Á48 pieces and OTC drug, are classified as a basic drug by the state authority and included in the medical insurance coverage in Yunnan. With the effect of dissipating stasis, stopping bleeding and relieving swelling & pains, the capsules are mainly used for external wound bleeding and injury-related swelling, demonstrating good effect in treatment of weapon injuries and other external wounds. 

      In addition to the effect and quality of the panax notoginseng capsules, Daphne's effort in contending for the tender pays off at last, including perfect bidding documents and Chairman Tang's leadership in the bid. 

      Winning of the tender means finding of a way to Shanghai hospitals. It will bring qualitative leap to Daphne's production and sales of the panax notoginseng capsules, and add a highlight to Daphne's business!